APM
IMGN

Avidity Partners Management’s Immunogen Inc IMGN Stock Holding History

Avidity Partners Management’s Portfolio IMGN Stock Details IMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-1,829,215
Closed -$54.2M – 108
2023
Q4 		$54.2M Sell
1,829,215
-88,692
-5% -$1.77M 1.98% 17
2023
Q3 		$30.4M Sell
1,917,907
-79,893
-4% -$1.33M 1.23% 38
2023
Q2 		$37.7M Buy
+1,997,800
New +$23.6M 1.32% 32

Other funds holding IMGN

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Avidity Partners Management's IMGN Position: Q1 2024 in Review

Avidity Partners Management sold out of Immunogen Inc (IMGN) in Q1 2024, closing a stake of 1,829,215 shares — an estimated $54.2M sold.

Avidity Partners Management first reported a position in IMGN in Q2 2023 and held it in 3 quarters. The position peaked at $54.2M in Q4 2023. 3 funds tracked by Wall St. Rank hold IMGN as of Q1 2024.

  • Avidity Partners Management reported no remaining Immunogen Inc position as of Q1 2024 after selling out during the quarter.
  • Avidity Partners Management sold 1,829,215 Immunogen Inc shares in Q1 2024, an estimated $54.2M.
  • Avidity Partners Management first reported a position in Immunogen Inc in Q2 2023 and held it in 3 quarters.
  • Avidity Partners Management's Immunogen Inc position peaked at $54.2M in Q4 2023.
  • 3 funds tracked by Wall St. Rank held Immunogen Inc as of Q1 2024.

Based on Avidity Partners Management's 13F filing for Q1 2024, filed 15 May 2024.